Abstract
Pathology underlying congenital forms of myasthenia gravis has been delineated through microscopic and electrophysiologic studies over the past 15 years. Differentiation from the immune-mediated disorder is crucial because therapy appropriate for acquired myasthenia may be harmful to patients with congenital disease.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Action Potentials
-
Antibodies / blood
-
Biopsy
-
Diagnosis, Differential
-
Electromyography
-
Humans
-
Motor Endplate
-
Myasthenia Gravis / classification
-
Myasthenia Gravis / congenital*
-
Myasthenia Gravis / diagnosis
-
Receptors, Cholinergic / immunology
-
Referral and Consultation
-
Synaptic Transmission*
Substances
-
Antibodies
-
Receptors, Cholinergic